Assessing changes in tumour vascular function using dynamic contrast‐enhanced magnetic resonance imaging
Top Cited Papers
Open Access
- 20 February 2002
- journal article
- research article
- Published by Wiley in NMR in Biomedicine
- Vol. 15 (2) , 154-163
- https://doi.org/10.1002/nbm.756
Abstract
Dynamic contrast‐enhanced MRI (DCE‐MRI) is widely used in the diagnosis and staging of cancer and is emerging as a promising method for monitoring tumour response to treatment. However, DCE‐MR imaging techniques are still evolving and methods of image analysis remain variable and non‐standard, and range from relative changes in the pattern of enhancement to pharmacokinetic modelling of contrast agent uptake. The combination of results from different institutions is therefore difficult and the sensitivities of different methods have not been compared. The purpose of this study is to investigate correlations between qualitatative and quantitative methods of analysis for DCE‐MR images from breast cancer patients undergoing neo‐adjuvant chemotherapy. Fifteen patients underwent DCE‐MRI examinations before and after one course of chemotherapy. Changes in the temporal pattern of signal enhancement, the rate and amplitude of enhancement and the volume transfer constant of contrast agent between the blood plasma and the extravascular extracellular space (EES), Ktrans, and the EES fractional volume, νe, were determined. In addition, whole tumour region‐of‐interest analysis was compared with histogram analysis to investigate the extent of tumour heterogeneity. It was found that changes in the rate of enhancement correlated strongly with changes in Ktrans values (Kendall's τ = 0.68, P < 0.001). Furthermore, it was found that the shape of the signal enhancement curve only changed when the Ktrans values changed by 50% or more. Median Ktrans values determined following histogram analysis of pixel maps of Ktrans were approximately equal to those determined by whole tumour region‐of‐interest analysis. The absolute change in the Ktrans values correlated negatively with the pre‐treatment values, particularly for responding patients. Thus, for higher pre‐treatment Ktrans values, a greater decrease was observed. Greater changes were observed in the upper extremes of the Ktrans histogram than in the median values after one course of treatment. Copyright © 2002 John Wiley & Sons, Ltd.Keywords
This publication has 34 references indexed in Scilit:
- Measurement of clinical and subclinical tumour response using [18F]-fluorodeoxyglucose and positron emission tomography: review and 1999 EORTC recommendationsEuropean Journal Of Cancer, 1999
- Prediction of tumor control in patients with cervical cancer: analysis of combined volume and dynamic enhancement pattern by MR imaging.American Journal of Roentgenology, 1998
- Microvessel density in invasive breast cancer assessed by dynamic gd‐dtpa enhanced MRIJournal of Magnetic Resonance Imaging, 1997
- Modeling tracer kinetics in dynamic Gd‐DTPA MR imagingJournal of Magnetic Resonance Imaging, 1997
- Observer variability in the interpretation of contrast enhanced MRI of the breastThe British Journal of Radiology, 1996
- Angiogenic response of MCF7 human breast cancer to hormonal treatment: Assessment by dynamic GdDTPA‐enhanced MRI at high spatial resolutionJournal of Magnetic Resonance Imaging, 1996
- Quantitative Analysis of Dynamic Gd‐DTPA Enhancement in Breast Tumors Using a Permeability ModelMagnetic Resonance in Medicine, 1995
- Studies of Gd‐DTPA relaxivity and proton exchange rates in tissueMagnetic Resonance in Medicine, 1994
- Contrast-Enhanced Magnetic Resonance Imaging of the BreastActa Oncologica, 1992
- Measurement of the blood‐brain barrier permeability and leakage space using dynamic MR imaging. 1. Fundamental conceptsMagnetic Resonance in Medicine, 1991